The present study was performed to investigate the incidence and diagnostic rate of CKD, the rate of PTH testing, and the status of SHPT treatment in patients with stage 3 to 5 CKD in a single hospital in China over 16 years. This evidence concerns the gene PTH and chronic kidney disease.